Key result
Management of electrical storm in Brugada syndrome requires elimination of precipitating factors, isoproterenol, and oral quinidine, followed by ablation if initial measures fail.
Why the study?
What is the recommended treatment approach for electrical storms in patients with Brugada syndrome?
What is the recommended treatment approach for electrical storms in patients with Brugada syndrome?
The management of electrical storm in Brugada syndrome requires elimination of precipitating factors, followed by isoproterenol and oral quinidine, with ablation reserved for refractory cases.
Supports stepwise management of Brugada electrical storm; leaves open need for randomized confirmation.
Patients with Brugada syndrome (BrS) not uncommonly suffer from recurrent and recalcitrant ventricular fibrillation episodes, the so‐called “electrical storm” which is malignant and potentially lethal event. While electrical storm in BrS is a therapeutic challenge, fortunately there are effective therapeutic solutions which must be compulsory applied: Elimination of precipitating factors, isoproterenol and oral quinidine are the first 2 therapeutic steps that one must urgently commenced. And if this measure should fail, ablation of the triggering ventricular premature beats and/or substrate ablation at the anterior aspect of the right ventricular outflow tract should be performed.
No takes yet. Share an insight, caveat, or question.
Veerakul et al. (2013) conducted a review in Brugada syndrome with electrical storm. Isoproterenol, oral quinidine, and ablation was evaluated. Management of electrical storm in Brugada syndrome requires elimination of precipitating factors, isoproterenol, and oral quinidine, followed by ablation if initial measures fail.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: